Published in J Exp Med on October 01, 1986
Two high-affinity interleukin 1 receptors represent separate gene products. Proc Natl Acad Sci U S A (1989) 2.13
Evidence for different interleukin 1 receptors in murine B- and T-cell lines. Proc Natl Acad Sci U S A (1989) 1.90
Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci U S A (1989) 1.82
Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci U S A (1990) 1.57
Kinetics of gamma interferon binding and induction of major histocompatibility complex class II mRNA in Leishmania-infected macrophages. Proc Natl Acad Sci U S A (1988) 1.32
Regulation of interleukin 1 and its receptor in human keratinocytes. Proc Natl Acad Sci U S A (1989) 1.26
Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways: role of protein kinase C. Cell Regul (1991) 1.14
Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis. J Clin Invest (1988) 1.11
Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc Natl Acad Sci U S A (1989) 1.11
Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha. Biochem J (1989) 0.96
Cytokines and cytokine measurements in a clinical laboratory. Clin Diagn Lab Immunol (1994) 0.93
Ca2+ responses to interleukin 1 and tumor necrosis factor in cultured human skin fibroblasts. Possible implications for Reye syndrome. J Clin Invest (1991) 0.93
The interleukin-1 receptor in Raji human B-lymphoma cells. Molecular characterization and evidence for receptor-mediated activation of gene expression. Biochem J (1989) 0.91
Interleukin 1-induced calcium signalling in chondrocytes requires focal adhesions. Biochem J (1997) 0.88
Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells. J Clin Invest (1988) 0.87
Analysis of mutations in the putative nuclear localization sequence of interleukin-1 beta. Biochem J (1991) 0.80
Differences in internalization and intracellular processing of interleukin-1 associated with the two forms of interleukin-1 receptor found in B-cells and T-cells. Biochem J (1991) 0.76
Proliferation in vitro of Lyt2-,L3T4- thymocytes shows responsiveness to interleukin 1. Clin Exp Immunol (1988) 0.76
Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor. J Clin Invest (1997) 0.75
Modulatory effects of chitosan adipate on the T and B lymphocyte subsets in mice. J Vet Sci (2006) 0.75
Interleukin 1 receptors and biological responses. Yale J Biol Med (1990) 0.75
Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol (1978) 28.92
Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature (1979) 17.18
T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med (1981) 10.66
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature (1985) 9.94
Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med (1984) 6.45
The functional relationship of the interleukins. J Exp Med (1980) 5.62
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51
Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures. J Exp Med (1974) 5.37
Interleukin 1 and T cell activation. Immunol Rev (1982) 5.00
Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors. Nature (1979) 4.72
Interleukin 2. Annu Rev Immunol (1984) 4.37
Two distinct factors are required for induction of T-cell growth. Nature (1980) 4.13
Interleukin 1: an immunological perspective. Annu Rev Immunol (1985) 4.09
Epidermal growth factor: morphological demonstration of binding, internalization, and lysosomal association in human fibroblasts. Proc Natl Acad Sci U S A (1978) 4.03
Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med (1985) 3.00
Nerve growth factor receptors. Characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells. J Biol Chem (1979) 2.90
Complementation patterns of Thy-1 variants and evidence that antigen loss variants "pre-exist" in the parental population. J Natl Cancer Inst (1974) 2.89
Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies. J Biol Chem (1984) 2.61
T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. Proc Natl Acad Sci U S A (1981) 2.51
125I-insulin binding to cultured human lymphocytes. Initial localization and fate of hormone determined by quantitative electron microscopic autoradiography. J Clin Invest (1978) 2.47
High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J Exp Med (1986) 2.37
The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1. J Immunol (1985) 2.14
Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc Natl Acad Sci U S A (1986) 2.12
Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells. Nature (1980) 1.99
Macrophage-independent activation of helper T cells. I. Production of Interleukin 2. J Immunol (1980) 1.96
Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature (1985) 1.90
A rapid biologic assay for the detection of interleukin 1. J Immunol (1983) 1.77
Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line. Proc Natl Acad Sci U S A (1986) 1.70
Binding of the differentiation-inducer, granulocyte-colony-stimulating factor, to responsive but not unresponsive leukemic cell lines. Proc Natl Acad Sci U S A (1984) 1.59
Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction. J Immunol (1985) 1.53
Effect of interleukin 1 on human thymocytes and purified human T cells. J Exp Med (1981) 1.50
Retention of biological activity following radioiodination of human interleukin 2: comparison with biosynthetically labeled growth factor in receptor binding assays. J Immunol Methods (1985) 1.27
Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones. J Immunol (1985) 1.22
Differential requirements for the induction of interleukin 2 responsiveness in L3T4+ and Lyt-2+ T cell subsets. J Exp Med (1985) 1.22
Insulin receptors convert to a higher affinity state subsequent to hormone binding. A two-state model for the insulin receptor. J Biol Chem (1982) 1.16
Cell surface antigen marking the stages of murine T cell ontogeny and its functional subsets. Immunol Rev (1984) 0.98
Alkaline phosphatase in hematopoietic tumor cell lines of the mouse: high activity in cells of the B lymphoid lineage. J Immunol (1981) 0.96
Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity (1999) 8.33
The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell (1988) 5.33
Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol (1987) 5.07
HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science (1988) 4.77
Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature (1985) 4.22
Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol (2001) 3.89
An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature (1995) 3.78
cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science (1988) 3.56
Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol (2000) 2.99
Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med (1984) 2.74
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol (1999) 2.58
IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity (1997) 2.54
Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice. J Exp Med (1994) 2.53
Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J (1993) 2.50
Selectively increased production of interferon-gamma by subsets of Lyt-2+ and L3T4+ T cells identified by expression of Pgp-1. J Immunol (1987) 2.39
Growth of mouse megakaryocyte colonies in vitro. Proc Natl Acad Sci U S A (1975) 2.38
Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes. J Exp Med (1987) 2.35
Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol (1998) 2.33
Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev (1980) 2.32
High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J Immunol (1985) 2.20
A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol (1987) 2.17
Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell (1993) 2.11
Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity (1998) 2.03
Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med (2001) 2.02
Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood. Scand J Immunol (1975) 1.94
Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature (1985) 1.90
Allograft immunity in the mouse. II. Physical studies of the development of cytotoxic effector cells from their immediate progenitors. J Immunol (1973) 1.89
Deletion of self-reactive T cells before entry into the thymus medulla. Nature (1988) 1.88
Superantigens of mouse mammary tumor virus. Annu Rev Immunol (1995) 1.86
Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice. J Immunol (1999) 1.82
Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J Immunol (1979) 1.82
Granzyme A is an interleukin 1 beta-converting enzyme. J Exp Med (1995) 1.81
Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation. J Immunol (2000) 1.79
Postnatal disappearance of self-reactive (V beta 6+) cells from the thymus of Mlsa mice. Implications for T cell development and autoimmunity. J Exp Med (1989) 1.78
Circulatory effects of heroin in patients with myocardial infarction. Lancet (1967) 1.75
Two monoclonal rat antibodies with specificity for the beta-chain variable region V beta 6 of the murine T-cell receptor. Proc Natl Acad Sci U S A (1988) 1.75
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity (1997) 1.74
The cellular basis of T-cell memory. Annu Rev Immunol (1989) 1.70
Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J Exp Med (1993) 1.67
H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. J Exp Med (1992) 1.64
Quantitative impact of thymic clonal deletion on the T cell repertoire. J Exp Med (1997) 1.64
Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors. Immunol Rev (1982) 1.63
T cell antigen receptor expression in athymic (nu/nu) mice. Evidence for an oligoclonal beta chain repertoire. J Exp Med (1987) 1.61
Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors. J Immunol (1985) 1.61
Effect of intravenous propranolol on the systemic circulatory response to sustained handgrip. Am J Cardiol (1966) 1.59
Phenotypic identification of memory cytolytic T lymphocytes in a subset of Lyt-2+ cells. J Immunol (1987) 1.56
Cytolytic T lymphocytes. Annu Rev Immunol (1983) 1.54
Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction. J Immunol (1985) 1.53
Two waves of recombinase gene expression in developing thymocytes. J Exp Med (1994) 1.52
In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-. Eur J Immunol (1995) 1.50
Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells. J Immunol (1986) 1.49
Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins. J Virol (1989) 1.49
Age-associated increase in expression of the T cell surface markers Thy-1, Lyt-1, and Lyt-2 in congenitally athymic (nu/nu) mice: analysis by flow microfluorometry. J Immunol (1981) 1.48
Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization. J Exp Med (1982) 1.48
An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J Exp Med (1992) 1.45
In vivo responses of CD4+ and CD8+ cells to bacterial superantigens. Eur J Immunol (1992) 1.45
Clonal analysis of cytolytic T lymphocyte specificity. I. Phenotypically distinct sets of clones as the cellular basis of cross-reactivity to alloantigens. J Exp Med (1980) 1.43
A role for gamma delta + T cells during experimental infection of mice with Leishmania major. J Immunol (1993) 1.42
Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2: heterogeneity of inhibition at the clonal level. J Immunol (1981) 1.42
Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes. Eur J Immunol (1989) 1.39
Functional analysis of T cell subsets from mice bearing the lpr gene. J Immunol (1985) 1.38
Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response. J Immunol (1995) 1.35
Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures. J Immunol (1984) 1.33
T-cell activation. Annu Rev Cell Biol (1986) 1.31
Activated B cells express functional Fas ligand. Eur J Immunol (1996) 1.30
Secretion of IgG1 induction factor by T cell clones and hybridomas. Eur J Immunol (1985) 1.29
Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J Exp Med (1993) 1.29
A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol (1991) 1.29
Gene transfer of the Ly-3 chain gene of the mouse CD8 molecular complex: co-transfer with the Ly-2 polypeptide gene results in detectable cell surface expression of the Ly-3 antigenic determinants. Eur J Immunol (1988) 1.29
Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci U S A (1990) 1.28
Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. J Exp Med (2000) 1.26
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur J Immunol (1999) 1.26
Clonal deletion of self-reactive T cells in irradiation bone marrow chimeras and neonatally tolerant mice. Evidence for intercellular transfer of Mlsa. J Exp Med (1989) 1.26
Generation of cytotoxic T lymphocytes in vitro. IV. Functional activation of memory cells in the absence of DNA synthesis. J Exp Med (1975) 1.26
Heterogeneity of in vitro colony- and cluster-forming cells in the mouse marrow: segregation by velocity sedimentation. J Cell Physiol (1975) 1.25
Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med (1996) 1.25
Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors. J Exp Med (1981) 1.25
Cloning and expression of the chicken interferon-gamma gene. J Interferon Cytokine Res (1995) 1.25
Production and characterization of monoclonal anti-Thy-1 antibodies that stimulate lymphokine production by cytolytic T cell clones. Eur J Immunol (1985) 1.25
Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization. J Immunol (1973) 1.25
Stringent V beta requirement for the development of NK1.1+ T cell receptor-alpha/beta+ cells in mouse liver. J Exp Med (1996) 1.22
Abnormal distribution of T cell subsets in athymic mice. J Immunol (1986) 1.22
Vacuolar H(+)-translocating pyrophosphatase is induced by anoxia or chilling in seedlings of rice. Plant Physiol (1995) 1.22
Differential requirements for the induction of interleukin 2 responsiveness in L3T4+ and Lyt-2+ T cell subsets. J Exp Med (1985) 1.22
Cutting edge: apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo. J Immunol (1999) 1.22
Cell separation analysis of B and T lymphocyte differentiation. Transplant Rev (1975) 1.21
Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J Exp Med (1995) 1.21
Generation of cytotoxic T lymphocytes in vitro. III. Velocity sedimentation studies of the differentiation and fate of effector cells in long-term mixed leukocyte cultures. J Exp Med (1974) 1.21
Flow microfluorometric analysis of mouse thymus development in vivo and in vitro. Eur J Immunol (1983) 1.20